Update on Greenlight laser vaporization (PVP) 2014.

Area of Science:

• Urology
• Minimally Invasive Surgery
• Laser Technology

Background:

• Benign prostatic hyperplasia (BPH) affects millions of men globally, necessitating effective treatment options.
• Photoselective vaporization of the prostate (PVP) using Greenlight laser has emerged as a popular minimally invasive BPH treatment.
• Assessing the comprehensive outcomes and complication profile of PVP is crucial for clinical decision-making.

Purpose of the Study:

• To systematically review the outcomes of photoselective vaporization of the prostate (PVP) using Greenlight laser.
• To evaluate the intraoperative, perioperative, and long-term complications associated with PVP.
• To synthesize current evidence on the efficacy and safety of different Greenlight laser generations (80W, 120W, 180W).

Main Methods:

• Systematic review adhering to PRISMA guidelines.
• Inclusion of studies published between 2009 and 2014.
• Analysis of outcomes including micturition symptoms (IPSS, QoL) and voiding parameters (Qmax, PVR volume).

Main Results:

• All Greenlight laser generations demonstrated significant improvements in micturition symptoms and voiding parameters.
• Intraoperative complication rates were low.
• Data on sexual function showed heterogeneity, with a trend toward decreased erectile function in some patients. Perioperative and postoperative complication rates varied, influenced by documentation heterogeneity.

Conclusions:

• PVP offers statistically significant and clinically relevant improvements in voiding parameters and symptoms for prostates <100 ml.
• The procedure is characterized by high intraoperative and perioperative safety.
• Further long-term randomized controlled trial (RCT) data beyond 3 years are needed for all Greenlight laser generations to fully understand functional outcomes and complications.